PLRX vs SBAC · $77.3M cap vs P/E 30, rev $1.42B
Pliant Therapeutics Inc (PLRX) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Latest reported PLRX revenue for 2025-12-31 was $0. Net income was -$149.3M. PLRX currently screens at market cap $77.3M.
Latest reported SBAC revenue for 2026-06-30 was $1.42B. Net income was $383.6M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
PLRX currently screens at market cap $77.3M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the PLRX and SBAC stock pages for the full models.
Not investment advice.